The exact mechanisms that regulate cervical softening or ripening during pregnancy are not completely understood. The aim of this study was to estimate the effects of various agents on cervical softening during pregnancy in rats. Cervical resistance was examined after treatment with nitric oxide (NO) donors and inhibitors and different hormonal agents. Cervical resistance was significantly reduced (P < 0.05) in rats treated with the NO donors: sodium nitroprusside, molsidomine and prostaglandin E 2 . However, treatments with the NO synthase (NOS) inhibitors N ω -nitro-L-arginine methyl ester (L-NAME) and L-N 6 -1-iminoethyl-lysine (L-NIL), or the prostaglandin synthesis inhibitor, indomethacin, significantly increased resistance (P < 0.05). The antiprogesterone, onapristone, reduced cervical resistance and its effects were only partially blocked by the progesterone agonist, promegestone. Relaxin reduced cervical resistance and NOS inhibitors partially blocked the effect of relaxin. These studies demonstrate that NO regulates cervical ripening. Relaxin also softens the cervix and may act by stimulating NO synthesis. Progesterone seems important in the control of cervical ripening, but its role appears complex. NO and prostaglandin pathways may independently control ripening by acting in parallel or synergistically. Key words: cervical ripening/cervix/nitric oxide/pregnancy/prostaglandins
Introduction
Endogenous substances thought to control cervical ripening include progesterone (Chwalisz et al., 1991;  The cervix consists mostly of connective tissue including Chwalisz and Garfield, 1994) , prostaglandins (PG) (Calder collagen, elastin and the macromolecular components that et al., 1977) , cytokines , oestrogens make up the extracellular matrix. The extracellular stroma of (Cheah et al., 1995) and relaxin (Sherwood, 1988 ; Sherwood the cervix includes mainly thick collagen fibre bundles running et al., 1990) . Uterine contractility is also thought to be involved, in all directions and very small amounts of elastin, held at least in the dilatation and effacement phase of ripening. together by an amorphous matrix composed principally of However, the exact role of these factors and the sequence of proteoglycans, glycoproteins and water (Danforth, 1983; Yu events that regulates cervical function remain unclear. and . Collagen is responsible for the tensile Cervical ripening during parturition is thought to depend on strength, elastin imparts elasticity, and the matrix contributes extensive alteration within the connective tissue (Mori and Ito, to the integrity of the tissue. Smooth muscle is unevenly 1991; Leppert, 1998) . Cervical ripening has been assessed distributed throughout the cervix, with a wide variability across biochemically by assaying the various connective tissue comspecies. The cervix of certain animals, e.g. the rat, contains a ponents, physically by measuring the extensibility of isolated higher proportion of smooth muscle than that of humans cervical tissue and clinically by visual, digital or ultrasono- (Harkness and Harkness, 1959) . Studies in several species graphic examination (Kleissl et al., 1978 ; Downing and have shown that cervical water content and dry mass increase Sherwood, 1985; Granstrom et al., 1989; ; disproportionately during pregnancy, with the water to dry Cheah et al., 1995; Chwalisz et al., 1997) . Recently, the lightweight ratio more than doubling around parturition (Harkness induced fluorescence (LIF) of collagen has been used to and Harkness, 1959; Kleissl et al., 1978; Fitzpartick and analyse changes in the cervix during pregnancy (Glassman Dobson 1979; Kokenyesi, 1991). et al., 1995; Garfield et al., 1998; Shi et al., 1999) . The role of the cervix shifts between two opposing functions Nitric oxide (NO) has also been implicated in cervical during pregnancy. In order to hold the products of conception ripening. Studies in rats and guinea pigs (Buhimschi et al. , inside the uterus, the cervix has to resist tension and remain 1996; Chwalisz et al., 1997) as well as humans (Thomson closed and rigid throughout most of gestation. At term, et al., 1997 At term, et al., , 1998 suggest that NO effectively softens the however, a drastic change in cervical function is required in cervix. NO may actually represent the central mediator through order to accommodate stretch and delivery (Leppert, 1992) .
which the cervical effects of a number of hormonal and The cervix softens, dilates and effaces at term, a process inflammatory factors converge. NO is thought to be regulated in part by progesterone (Ali et al., 1997; Chwalisz et al., referred to as cervical ripening. 1997), and cytokines (Nathan, 1992; Moncada and Higgs, 1993) . In turn, NO may control the structure and composition of the cervical extracellular matrix through its action on matrix metalloenzymes which, like guanylate cyclase (the target of NO in vascular smooth muscles), are haeme-containing enzymes (Trachtman et al., 1995) . The objective in this study was to investigate and to characterize the effect of various hormones and other substances on cervical resistance during pregnancy.
Materials and methods

Animals
Timed-pregnant Sprague-Dawley rats (200-250 g, Charles River Figure 1 . Resistance in isolated rat cervices at day 14 of gestation. Laboratories, Wilmington, MA, USA) were housed separately and
The cervices were incubated for 30 min in control (Kreb's solution, allowed free access to food and water. The animals were maintained n ϭ 6) or calcium-free solutions with EGTA (Ca 2ϩ -free, 0.5 mmol/ l, n ϭ 6) and then cervical resistance was extricated in the same on a constant 12 h light:12 h dark cycle. The pregnant rats had a solution. The slope is the slope of the stress-strain curve when the gestational period of 22 days, day 1 being the day on which the tension of force of resistance is plotted against the distance of sperm plug was observed. The animals were anaesthetized with a stretch. Data are presented as mean Ϯ SEM. There was no combination of xylazine (Gemini, Burns Veterinary Supply Inc, significant difference between the two groups (unpaired Student's Rockville Center, NY, USA) and ketamin HCl (Ketaset; Fort Dodge t-test). Laboratories Inc, Fort Dodge, IO, USA) for the intravaginal application of the agents and killed by CO 2 inhalation prior to tissue collection. All procedures were approved by the Animal Care and Use Committee of the University of Texas Medical Branch at agonist; onapristone (ZK98299; Schering AG, Berlin, Germany), an Galveston.
antiprogestin; and porcine relaxin (Dr Sherwood, University of Illinois, Urbana, IL, USA).
Measurement of cervical resistance
The whole cervix, defined as the least vascular tissue with two parallel Statistical analysis lumina between the uterine horns and the vagina, was collected.
Statistical comparisons between two groups were performed with Connective tissue and fat were removed and the cervix was suspended unpaired Student's t-test and between multiple groups using one-way with its longitudinal axis vertically in a 10 ml organ chamber for analysis of variance (ANOVA) followed by Student-Newman-Keuls isometric tension recording (cervimeter). The chamber was filled with test. P Ͻ 0.05 was considered to be statistically significant. Results physiological Kreb's solution, bubbled with a mixture of 95% O 2 / are expressed as means Ϯ SEM. 5% CO 2 , and maintained at 37°C. Using hooks inserted through each of the canals, the lower side of the cervix was fixed to the bottom of the organ chamber while the upper was connected to a force transducer which in turn was connected to an online computer. The cervimeter
Results
was controlled by a servo device that stretched the isolated cervix Effect of cervical smooth muscle contractility on incrementally in steps of 0.2 mm at 1 min intervals while the tension cervical resistance was continuously recorded. The resultant length-tension curve had a Cervical resistance was measured in isolated cervices from saw-tooth appearance. As with all actively elastic tissues, each incremental stretch resulted in a sharp rise in tension followed by day 14 pregnant rats in calcium-free solutions with EGTA accommodation and an exponential decrease to a stable tension that (0.5 mmol/l) and in physiological Kreb's solution. Calciumwas higher than the plateau at the previous length. The slope of the free ϩ EGTA treatment was expected to prevent contraction regression line through the linear portion of the length-tension curve of smooth muscle in the cervix and to allow measurement of was derived and used as an indication of cervical extensibility. The the resistance of the cervical connective tissue without the slope of the length-tension curve is related directly to cervical contribution of smooth muscle contraction. There was no resistance and inversely to compliance (Chwalisz et al., 1991) . The significant difference between cervical resistance measured in more resistant, less compliant, the cervix, the steeper is the change normal Krebs' and that measured in calcium-free solutions in tension in response to each increment in length.
( Figure 1 ).
Reagents
The following drugs were used in this study and were obtained from
Effects of NOS inhibitors on cervical resistance
Sigma (St Louis, MO, USA), unless otherwise stated: ethylene L-NAME (a non-selective NOS inhibitor, 50 mg/day/rat) or Lglycol-bis (β-aminoethyl ether) EGTA, a calcium chelating agent; NIL (a selective iNOS inhibitor, 1 mg/day/rat) were given via N ω -nitro-L-arginine methyl ester (L-NAME), a non-specific nitric osmotic minipumps implanted s.c. Animals were treated for oxide synthase (NOS) inhibitor; L-N 6 -1-iminoethyl-lysine (L-NIL), a 3, 5 or 9 days before being killed on day 21 of gestation. The selective inducible NOS inhibitor (Alexis, San Diego, CA, USA); resistance to stretch was significantly elevated after 5 days N-ethoxycarbonyl-3-[4morpholinyl] sydnone imine (molsidomine), a treatment with the NOS inhibitor L-NAME (Figure 2A ), but NO donor; sodium nitroprusside (SNP), a NO donor; methyl cellulose; not after 3 or 9 days. The results with L-NIL were similar to PGE 2 gel (Prepidil; Upjohn, Kalamazoo, MI, USA); indomethacin, a prostaglandin synthesis inhibitor; promegestone (R5020), a progestin those obtained with L-NAME ( Figure 2B ). intravaginally with either SNP (0.3 mg/day in 0.3 ml nitro-L-arginine methyl ester (L-NAME), on cervical resistance to methycellulose gel, n ϭ 9), L-NAME (0.3 mg/day in 0.3 ml stretch. Cervices were isolated and resistance measured at day 21 methycellulose gel, n ϭ 8) or vehicle (control, methycellulose gel of gestation after 3 (n ϭ 6), 5 (n ϭ 4) and 9 (n ϭ 6) days alone, n ϭ 6) daily for 3 days. Data are presented as mean Ϯ treatment with L-NAME (50 mg/day) or vehicle (control, saline, SEM. Values with common superscript are not significantly n ϭ 5) in osmotic minipumps. Data presented as mean Ϯ SEM. different compared to control (unpaired Student's t-test). (B) The (B) The time-dependent effect of the NOS inhibitor, L-N 6 -1-effect of molsidomine (MOL), a long-acting NO donor, on cervical iminoethyl-lysine (L-NIL) on cervical resistance to stretch. Cervices resistance to stretch. Pregnant rats were treated with either MOL were isolated and resistance measured at day 21 of gestation after 3 (n ϭ 9) in drinking water (15 mg/day/kg) or vehicle (control, water (n ϭ 6), 5 (n ϭ 6) and 9 (n ϭ 6) days treatment with L-NIL with equal amounts of ethanol, n ϭ 9) from day 14 until day 17 of (1 mg/day) or vehicle (control, saline, n ϭ 5) in osmotic gestation. Data presented as mean Ϯ SEM. *Mean values of the minipumps. Data presented as mean Ϯ SEM. a,b Values with two groups were significantly different (unpaired Student t-test). common superscripts are not significantly different (one-way analysis of variance followed by Student-Newman-Keuls test).
Effects of NO donor and NOS inhibitor on cervical
Rats were treated for 3 days with the longer-acting NO resistance donor molsidomine (15 mg/kg/day) added to the drinking water on day 14 of gestation. Molsidomine significantly Rats were treated intravaginally daily with the NO donor, sodium nitroprusside, or the NOS inhibitor, L-NAME, on day reduced the cervical resistance to stretch compared with control ( Figure 3B ). 14 of gestation. Sodium nitroprusside (0.3 mg) or L-NAME (0.3 mg) were dissolved in saline and mixed with methylcelluEffect of PGE 2 on cervical resistance lose gel to a final volume of 0.3 ml. Control animals were treated with the vehicle (methycellulose gel) only. Cervices
Starting on day 14 of pregnancy, rats were treated with PGE 2 gel (0.1 mg/day) intravaginally or gel alone (control), were collected after 3 days treatment on day 17 of gestation. Sodium nitroprusside significantly reduced cervical resistance indomethacin (3 mg/day) via osmotic minipumps or vehicle control. Cervices were removed and resistance was measured compared with control ( Figure 3A) . Treatment with sodium nitroprusside for shorter periods resulted in variable degrees on day 17 of gestation. The PGE 2 gel (Prepidil) decreased cervical resistance ( Figure 4A ), while indomethacin significof softening. Treatment with L-NAME locally did not change cervical resistance significantly, compared with control antly increased cervical resistance, compared with control ( Figure 4B ). (Figure 3A) . Rats on day 14 of pregnancy were treated intravaginally with PGE 2 , Prepidil (PRE; 0.1 mg/day, n ϭ 8) or gel alone (control, n ϭ 7) daily for 3 days. Cervices were removed and resistance was measured on day 17 of gestation. Data are presented as mean Ϯ SEM. (B) Effect of prostaglandin inhibition with indomethacin on cervical resistance. Rats on day 14 of pregnancy were treated with indomethacin (IND, 3 mg/day, n ϭ 6) or vehicle (control, saline, Figure 6 . Effect of relaxin with, and without, nitric oxide synthase n ϭ 7) via osmotic minipumps. Cervices were removed and (NOS) inhibitors, on cervical resistance. Pregnant rats at day 14 resistance was measured on day 17 of gestation. Data are presented were treated with relaxin (R, 50 µg/day, n ϭ 14), N ω -nitro-Las mean Ϯ SEM. *Mean values are significantly different (unpaired arginine methyl ester (L-NAME) (LN, 50 mg/day, n ϭ 6), L-N 6 -1-
iminoethyl-lysine (L-NIL, 1 mg/day, n ϭ 4), relaxin ϩ L-NAME (RϩLN, n ϭ 6), relaxin ϩ L-NIL (RϩL-NIL, n ϭ 4) and vehicle (control, saline, n ϭ 8) in osmotic minipumps. Cervices were
Effects of iNOS inhibitor and indomethacin on cervical
removed and examined on day 17 of gestation. One-way analysis alone or in combination. Starting on day 14 of pregnancy, the animals were treated with L-NIL (1 mg/day), indomethacin (3 mg/day), indomethacin ϩ L-NIL, or vehicle via osmotic without relaxin, L-NIL (1 mg/day) with or without relaxin, or vehicle via osmotic minipumps. Cervices were removed and minipumps. The rat cervices were examined on day 17 of gestation. Similar to the results noted above with 3 days examined on day 17 of gestation. Relaxin significantly reduced cervical resistance, compared with control ( Figure 6 ). Cervical treatment, L-NIL had little effect on cervical extensibility while indomethacin significantly increased cervical resistance (Figure resistance in rats treated with combinations of relaxin ϩ L-NAME was slightly higher than those treated with relaxin 5). Combinations of indomethacin with L-NIL increased stretch resistance to significantly higher values than L-NIL alone only but this effect did not reach statistical significance. Addition of L-NIL to relaxin, however, significantly increased ( Figure 5) .
the resistance compared with relaxin alone.
Effects of relaxin and NOS inhibition on cervical resistance Effect of progesterone on cervical resistance
Timed pregnant rats on day 17 of pregnancy were treated Timed pregnant rats on day 14 of pregnancy were treated with either relaxin (50 µg/day), L-NAME (50 mg/day) with or with onapristone (antiprogestin, 10 mg/rat), promegestone ance. However, the progestin agonist promegestone completely failed to inhibit ripening caused by onapristone, even though it prevented preterm delivery. Indomethacin also prevented ripening and combinations of indomethacin with NOS inhibitors were more effective than either indomethacin or NOS inhibitors alone in suppressing ripening. Relaxin effectively ripened the cervix and this effect was reversed by NOS inhibition. These data indicate that cervical ripening is controlled by a complex series of steps involving NO, prostaglandins and progesterone. Recently various authors Chwalisz et al., 1997; Thomson et al., 1997 Thomson et al., ,1998 have Figure 7 . Effects of the progesterone agonists, promegestone and suggested that NO may be involved in cervical ripening as onapristone on cervical resistance. Pregnant rats were treated with onapristone (O, 10 mg, n ϭ 6), promegestone (P, 2 mg, n ϭ 6), one of the local mediators of the inflammatory cascade during vehicle (control, sesame oil, n ϭ 6) or onapristone ϩ promegestone term and preterm labour. This study suggests that NOS activity (OϩP, n ϭ 6) administered s.c. on day 17 of gestation. The rats is present in the cervix because competitive inhibitors (L-NIL were killed and cervical resistance was measured 6, 12 or 24 h and L-NAME) block cervical ripening. Inducible NOS (iNOS), after the start of treatments. At 24 h the animals were bleeding a cytokine inducible enzyme, is found in the cervix and is up- et Ali et al., 1997) , amounts of NO and NOS were noted to be moderately elevated during the period of decreased (progestin agonist, 2 mg/rat), vehicle (control group, sesame cervical resistance shown in the current study (days 12-18 oil) or combination of onapristone ϩ promegestone adminisgestation) and then rose significantly on the day of delivery. tered s.c.. The rats were killed and cervical resistance was Nevertheless, Chwalisz et al. have shown that treatment of the measured 6, 12 or 24 h after the start of treatment. There was cervix with a NO donor (sodium nitroprusside) locally in a decline in cervical resistance in control rats consistent with guinea pigs significantly increases cervical extensibility progressive ripening during the 24 h period (Figure 7) . In (Chwalisz et al., 1997) , a finding confirmed in rats in the onapristone-treated rats, premature ripening was induced and present study. Additionally, our preliminary studies (Buhimschi the animals began to deliver prematurely~24 h after treatment. et al., 1996) and the present results in rats have shown that LThe resistance to stretch in the onapristone group was signific-NAME inhibits cervical ripening when given systemically in antly reduced, compared with controls at all time periods. At minipumps, but not locally. Subsequent studies in humans also 12 and 24 h, promegestone increased cervical resistance, indicate that NO donors ripen the cervix when applied during compared with the control, but the difference was not statisticthe first trimester (Thomson et al., 1997 (Thomson et al., , 1998 . The effect of ally significant. Promegestone inhibited premature delivery NO donors on the human cervix was evident within 3 h produced by onapristone and increased cervical resistance, whereas 2-3 days were required in guinea pigs (Chwalisz compared with onapristone, but the difference again failed to et al., 1997) and rats (this study). The reason for the longer achieve statistical significance (Figure 7) . period of treatment required in guinea pigs and rats is not clear. Similarly, NO inhibitors require several days treatment to prevent ripening. This may be because once softening has Discussion started due to enzymatic activity it may be difficult to arrest. Previous studies have indicated that cervical ripening, as It is also possible that NO also inhibits cervical contractility measured by two independent methods (cervical resistance and that NO donor treatment results in dilation once softening and light-induced fluorescence of collagen), is a gradual and has occurred. Immediate relaxing effects of NO on cervical progressive process occurring during the last half of pregnancy smooth muscle have been observed (Ekerhovd et al., 1998) . (Garfield et al., 1999; Shi et al., 1999) . In this study, it Thus NO could control the slow process of softening as well was demonstrated that the physiological process of cervical as the more rapid dilation process. Dilation was not examined softening or ripening is controlled by various mechanisms.
in this study, even though it is evident that lack of cervical Some of these mechanisms act independently, while others contractility does not affect cervical softening (Figure 1) . Thus, depend on the same final pathway. Treatment with NOS in addition to species variability, the differences in endpoints (L-NAME or L-NIL, Figure 2A ,B); and cyclo-oxygenase (COX) measured (dilatation versus resistance) and gestational period (indomethacin, Figure 4B ) inhibitors suppressed ripening at which NO was applied (early versus late) between the whereas NO donors (sodium nitroprusside or molsidomine, human and animal studies could have contributed to the Figure 3A ,B) and prostaglandins ( Figure 4A ) accelerated it. difference in response-time. In addition in the present study, These data show that NO and PG play important roles in the both systemic (i.e. osmotic minipumps, drinking water and regulation of cervical ripening.
s.c. treatments) and local (intravaginal) administration was It has also been shown that, in addition to inducing preterm labour, the antiprogestin onapristone decreased cervical resistused. This study suggests that it may be possible to manipulate the cervix by either route. However, this needs to be evalubecause the cervix becomes soft well before progesterone concentrations start to decline. ated further.
It has long been recognized that the cervix is composed Progesterone is also well known to control uterine contractility in rats during pregnancy (Csapo, 1981) . Progesterone mostly of connective tissue, with collagen being the dominant component (Danforth, 1947; Leppert, 1992) . During ripening, withdrawal, which begins at~day 19 of gestation and nadirs at term, is associated with a number of events thought to be remodelling of the collagen is believed to occur and facilitate dilatation during labour. It is often stated that 'the cervix ripens responsible for effective uterine contractility (e.g. increase in gap junctions, ion channels, excitatory receptors) (Puri and at term'. However, the results of recent studies indicate that softening, as measured by resistance estimates and cervical Garfield, 1982) . Since cervical softening is a slow process with changes appearing over the last 10 days of pregnancy collagen fluorescence, gradually increases during the second half of pregnancy rather than acutely at term (Garfield et al., (Shi et al., 1999) and increased uterine contractility and labour is an acute event occurring in the last 12-24 h prior to 1998; Shi et al., 1999) . Other studies in both rats and humans support the concept of a slow ripening process (Harkness and delivery, these two processes must be regulated by separate and independent mechanisms. Harkness, 1959; Ekman et al., 1991; Yu and Leppert, 1991) . Thus hormonal control must be exerted gradually during Progesterone withdrawal is also thought to control the influx of leukocytes into the cervix (Chwalisz et al., 1991) , and to pregnancy.
Hormones, especially progesterone (Chwalisz and Garfield, regulate cytokine synthesis (Ito et al., 1994) . The role of cytokines in the recruitment of leukocytes and stimulation of 1994), prostaglandins (Calder et al., 1977; Hollingsworth et al., 1980; Uldbjerg et al., 1981) and relaxin (Downing and NO and PG production by macrophages and other leukocytes is well-established (Nathan and Xie, 1994) . In return, NO can Sherwood, 1985) , are known to play an important role in control of cervical function. Progesterone seems to exert stimulate cytokine and prostaglandin synthesis (Corriveau et al., 1998; Cuthberston et al., 1998) . One might conclude overall control over cervical ripening, and the antiprogestins induce ripening in all species investigated to date, including that progesterone and its withdrawal control a sequence of increased cytokine synthesis, leukocyte recruitment, and humans (Chwalisz and Garfield, 1994) . The general consensus is that progesterone inhibits ripening and progesterone withincreased production of NO and prostaglandins. However, under these circumstances promegestone would be expected drawal at term promotes softening (Chwalisz et al., 1991) . Progesterone also reduces collagenase activity, leukocytic to prevent cervical ripening produced by onapristone if this step is receptor-mediated. This is clearly not the case ( Figure  migration , and suppresses interleukin (IL) synthesis (Jeffery and Koob, 1980; while antiprogestins promote 7). These data suggest that control of the cervix by progesterone is more complicated than the sequence suggested above. the opposite (Chwalisz et al., 1991) .
It was found that the antiprogestin used in the present study Prostaglandins are also thought to contribute to cervical ripening. Prostaglandins are believed to regulate the compon-(onapristone) effectively induced softening within 6 h, a significantly shorter time than that required to inhibit or induce ents of the cervical extracellular matrix in a number of ways. PGF 2α increases glycosaminoglycans and the activity of cervical softening with NO inhibitors or donors respectively. In contrast, treatment with promegestone failed to add to the hyaluronic synthases (Murota et al., 1977) . Prostaglandins have also been shown to stimulate cytokine synthesis and softening occurring in control tissues over the 24 h treatment period and did not prevent softening produced by onapristone, inhibit protease activity (Denison et al., 1999) . PGE 2 has been reported to stimulate 'collagenase activity' (Goshowaki et al., even though this combination has been shown to inhibit premature delivery (Garfield et al., 1987) . These data suggest 1988). However, PGE 2 may not actually stimulate collagenase activity (Rath et al., 1987a,b) . During cervical ripening, that the control of the cervix by progesterone is complex and may involve multiple pathways.
hyaluronic acid may induce the production of interleukin-1 (IL-1). PGE 2 seems to dilate small blood vessels in the cervix Progesterone inhibits, while antiprogestins stimulate, NO production and NOS synthesis in the cervix (Buhimschi et al., (Allen et al., 1988) which, in combination with a chemotactic effect (Lange 1983), may increase infiltration of the cervix 1996; Chwalisz et al, 1996; Ali et al., 1997) . However, the production of NO after onapristone ϩ promegestone or other with leukocytes. Prostaglandins have been used clinically for cervical ripening (Calder et al., 1977; Uldbjerg et al., 1981 ; progestins, does not appear to have been studied. It is possible that with the above combination (antiprogestin ϩ R5020), NO Forman et al., 1982) . The introduction of prostaglandins, in particular locally administered PGE 2 , to soften the cervix synthesis remains elevated.
Previous studies show that the cervix softens slowly over before labour induction, has been a major advance in obstetrics in the past decade. PGE 2 -induced cervical ripening is associated the last 10 days of gestation (Garfield et al., 1998; . This is the time when circulating plasma progesterone with a time-limited enzymatic collagen degradation, increased synthesis of non-collagenous proteins, and a substantial and uterine tissue concentrations are at their highest (Puri and Garfield, 1982) . Moreover, concentrations of progesterone are increase in hyaluronic acid concentration (Rath et al., 1990) . The present studies indicate that PGE 2 softens the rat cervix lower postpartum when the cervix reverts to a rigid state (Garfield et al., 1998; Shi et al., 1999) . Contrary to previous ( Figure 4A ) and indomethacin prevents softening ( Figure 4B ). These results are similar to the effects of NO donors and conclusions concerning progesterone and cervical function (see above), the results of the present study demonstrate that NO inhibitors ( Figure 3A,B) . Treatment of animals with a combination of indomethacin and L-NIL resulted in greater progesterone withdrawal does not control the softening process suppression of softening than either indomethacin or NO controls and this effect was inhibited by NO inhibitors ( Figure  6 ). Since the effect of relaxin does not involve prostaglandins inhibitors alone ( Figure 5 ). These data suggest that there are two independent, and perhaps parallel, pathways that may , relaxin appears to act specifically on the NO pathway and not the PG pathway regulating cervical interact synergistically to control ripening of the cervix. It is also well known that NO stimulates the production of softening (see above). prostaglandins by action on COX enzymes (Salvemini et al., 1993) . However it is unlikely that NO acts solely on COX to
